Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Biliary Tract Diseases

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 44 articles: HTML format

Single Articles

January 2026
1. SCOTTI GB, Zullo F, Mattana M, Covotta F, et al
   Fecal calprotectin in patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2026 Jan 13:102764.
   PubMed     Abstract available
   
   
   December 2025
2. LUCIANI L, Carlier C, Leuk L, Clarenne J, et al
   Clinical and economic outcomes of adding durvalumab to gemcitabine/cisplatin in advanced biliary tract cancers: A multicenter descriptive study.
   Clin Res Hepatol Gastroenterol. 2025;49:102733.
   PubMed     Abstract available
   
   
   
3. CORSI O, Jara C, Fernandez M, Pastore A, et al
   Is cholecystectomy a real risk factor for Metabolic dysfunction-associated steatotic liver disease (MASLD)? A longitudinal cohort study from a population with a high burden of gallbladder diseases.
   Clin Res Hepatol Gastroenterol. 2025;49:102732.
   PubMed     Abstract available
   
   
   September 2025
4. JAAN A, Najim MS, Maryyum A, Muhammad QUA, et al
   Safety and efficacy of index admission cholecystectomy in severity-stratified acute cholangitis hospitalizations.
   Clin Res Hepatol Gastroenterol. 2025;49:102676.
   PubMed     Abstract available
   
   
   
5. COSAR OS, Ozturk H, Kayhan G, Can A, et al
   GGT-normal cholestasis associated with LSR deficiency: A potential new subtype of PFIC.
   Clin Res Hepatol Gastroenterol. 2025;49:102674.
   PubMed     Abstract available
   
   
   
6. LEE SB, Jeon YJ, Lim DH
   CT-quantified visceral fat and risk of gallbladder stones in Korean men: A cross-sectional study of 2939 cases.
   Clin Res Hepatol Gastroenterol. 2025;49:102670.
   PubMed     Abstract available
   
   
   July 2025
7. PAOLANTONIO G, Benassi C, Natali GL
   Percutaneous transhepatic bilio-enteric neoanastomosis via the transseptal puncture system in a child with split liver transplant and severe occluded hepatico-jejunostomy.
   Clin Res Hepatol Gastroenterol. 2025;49:102654.
   PubMed     Abstract available
   
   
   
8. KIRCHGESNER J, Augustin J, Bazin T, Freiha P, et al
   A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis.
   Clin Res Hepatol Gastroenterol. 2025;49:102615.
   PubMed     Abstract available
   
   
   June 2025
9. GOYAL RM, Bansal B, Ayyad M, Singh A, et al
   Clinical outcomes in patients with autoimmune hepatitis and primary biliary cholangitis overlap syndrome in the United States.
   Clin Res Hepatol Gastroenterol. 2025;49:102598.
   PubMed     Abstract available
   
   
   
10. SANAVIO M, Camus M, Nammour JP, Godmer A, et al
    Clinical use of per ERCP bile aspiration in patients with cholangitis: The aspibile study.
    Clin Res Hepatol Gastroenterol. 2025;49:102599.
    PubMed     Abstract available
    
    
    April 2025
11. JAAN A, Zubair A, Farooq U, Nadeem H, et al
    Impact of frailty on outcomes and biliary drainage strategies in acute cholangitis: A retrospective cohort analysis.
    Clin Res Hepatol Gastroenterol. 2025;49:102568.
    PubMed     Abstract available
    
    
    January 2025
12. CORREIA FP, Coelho H, Francisco M, Alexandrino G, et al
    Predictive factors of spontaneous common bile duct clearance and unnecessary ERCP in patients with choledocholithiasis.
    Clin Res Hepatol Gastroenterol. 2025;49:102515.
    PubMed     Abstract available
    
    
    
13. SASAKI M, Sato Y, Nakanuma Y
    A heterogeneous subtype of biliary epithelial senescence may be involved in the pathogenesis of primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2025;49:102512.
    PubMed     Abstract available
    
    
    October 2024
14. CANCADO GGL, Fucuta PDS, Gomes NMF, Couto CA, et al
    Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102453.
    PubMed     Abstract available
    
    
    
15. ZHAO B, Xue J, Zhang H
    Causal effects of smoking, alcohol consumption, and coffee intake on hepatobiliary and pancreatic diseases: A Mendelian randomization study.
    Clin Res Hepatol Gastroenterol. 2024;48:102450.
    PubMed     Abstract available
    
    
    
16. WANG M, Liu X, Qiao C, Chen R, et al
    Association of congenital hepatic fibrosis and Caroli's syndrome: Two illustrative cases.
    Clin Res Hepatol Gastroenterol. 2024;48:102443.
    PubMed    
    
    
    
17. GU S, Hu S, Wang S, Shi C, et al
    Altered biliary microbial and metabolic profile reveals the crosstalk between NAFLD and cholelithiasis.
    Clin Res Hepatol Gastroenterol. 2024;48:102431.
    PubMed     Abstract available
    
    
    
18. SHEN P, Shi Y, Xu P, Rao L, et al
    The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2024;48:102430.
    PubMed     Abstract available
    
    
    August 2024
19. LIN YL, Yao T, Wang YW, Yu JS, et al
    Association between primary biliary cholangitis with diabetes and cardiovascular diseases: A bidirectional multivariable Mendelian randomization study.
    Clin Res Hepatol Gastroenterol. 2024;48:102419.
    PubMed     Abstract available
    
    
    
20. TAO M, Wang X, Han J, Cao L, et al
    A new classification and laparoscopic treatment of extrahepatic choledochal cyst.
    Clin Res Hepatol Gastroenterol. 2024;48:102413.
    PubMed     Abstract available
    
    
    
21. SALIN G, Ouidir N, Hoyeau N, Leenhardt R, et al
    A uncommon lesion of the ampulla of Vater.
    Clin Res Hepatol Gastroenterol. 2024;48:102406.
    PubMed    
    
    
    
22. LI C, Dong Y, Zhang Y, Wu C, et al
    Clinical significance of lncRNA XIST expression in cholangiocarcinoma and its effect on cell migration and invasion.
    Clin Res Hepatol Gastroenterol. 2024;48:102398.
    PubMed     Abstract available
    
    
    
23. HU J, Mi Y, Wang L, Jiang F, et al
    Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102394.
    PubMed     Abstract available
    
    
    June 2024
24. ZHAO G, Shi R, Ma M, Lin H, et al
    Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study.
    Clin Res Hepatol Gastroenterol. 2024;48:102363.
    PubMed     Abstract available
    
    
    
25. TANAKA A, Corpechot C
    PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old.
    Clin Res Hepatol Gastroenterol. 2024;48:102358.
    PubMed     Abstract available
    
    
    May 2024
26. MARTINELLI G, Stanca S, Bosco F, Zini L, et al
    Massive lymphatic embolism in gallbladder signet ring cell carcinoma: An autopsy finding.
    Clin Res Hepatol Gastroenterol. 2024;48:102330.
    PubMed    
    
    
    
27. SALIN G, Corpechot C, Ouazana S, Dong C, et al
    Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study.
    Clin Res Hepatol Gastroenterol. 2024;48:102324.
    PubMed     Abstract available
    
    
    
28. LIANG Y, Li J, Zhang Z, Jiang T, et al
    Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk.
    Clin Res Hepatol Gastroenterol. 2024;48:102321.
    PubMed     Abstract available
    
    
    April 2024
29. YUE X, Cao S, Chen Y
    Acantholytic squamous cell carcinoma of the gallbladder: Report of a rare case with diagnostic challenges.
    Clin Res Hepatol Gastroenterol. 2024;48:102316.
    PubMed    
    
    
    January 2024
30. SEXTON F, Shanahan W, Ryan JD
    Xanthoma striatum palmare: Getting a handle on hyperlipidaemia in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102255.
    PubMed    
    
    
    
31. NAYAGAM JS, Ahmed W, Farrant M, Jefferies J, et al
    Clinical factors associated with illness perception, worry and mental health in sclerosing cholangitis: A single centre prospective study.
    Clin Res Hepatol Gastroenterol. 2024;48:102251.
    PubMed     Abstract available
    
    
    December 2023
32. ZHENG L, Zhou N, Yang X, Wei Y, et al
    Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
    Clin Res Hepatol Gastroenterol. 2023;47:102244.
    PubMed     Abstract available
    
    
    
33. JANG H, Han N, Staatz CE, Kwak JH, et al
    Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023;47:102227.
    PubMed     Abstract available
    
    
    November 2023
34. PASCALE A, Rosmorduc O, Duclos-Vallee JC
    New epidemiologic trends in cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2023;47:102223.
    PubMed     Abstract available
    
    
    
35. MUTANEN A, Pakarinen MP
    Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102220.
    PubMed     Abstract available
    
    
    October 2023
36. FILANOVSKY K, Temper N, Stanevsky A, Shvidel L, et al
    Vanishing bile duct syndrome in a patient with multiple myeloma treated with bortizomib, lenalidomide and dexamethasone.
    Clin Res Hepatol Gastroenterol. 2023;47:102198.
    PubMed    
    
    
    
37. DI GIORGIO A, Sciveres M, Fuoti M, Sonzogni A, et al
    Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency.
    Clin Res Hepatol Gastroenterol. 2023;47:102185.
    PubMed     Abstract available
    
    
    
38. BOILLOT O, Guillaud O, Wischlen E, Ruiz M, et al
    Determinants of early surgical complications after pediatric liver transplantation: A single center/single surgeon experience over 20 years.
    Clin Res Hepatol Gastroenterol. 2023;47:102222.
    PubMed     Abstract available
    
    
    August 2023
39. VO QUANG E, Ithier G, Jager M, Plessier A, et al
    Cholangiopathy in sickle cell disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102166.
    PubMed    
    
    
    May 2023
40. WISCHLEN E, Laverdure N, Erard D, Rohmer B, et al
    Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
    Clin Res Hepatol Gastroenterol. 2023;47:102139.
    PubMed     Abstract available
    
    
    
41. MALKANI KV, Jesudian AB, Luo JJ, Schonfeld EA, et al
    Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102114.
    PubMed     Abstract available
    
    
    
42. YU AT, Khajoueinejad N, Gross A, Golas BJ, et al
    A possible role for ketorolac in the management of increased biliary drain output.
    Clin Res Hepatol Gastroenterol. 2023;47:102128.
    PubMed     Abstract available
    
    
    April 2023
43. SHIAU H, Schraw JM, Mysore K, Cavallo L, et al
    Characteristics of infections and their risk factors in children with biliary atresia.
    Clin Res Hepatol Gastroenterol. 2023;47:102109.
    PubMed     Abstract available
    
    
    
44. SASAKI M, Sato Y, Nakanuma Y
    An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2023;47:102106.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum